Among the healthcare industry’s many innovations in improving care is the analysis of data about patient outcomes. Komodo Health has created a “healthcare map” that applies artificial intelligence to track about 325 million U.S. patients to identify unmet needs throughout the healthcare value chain. The goal is to help payers, providers and drug makers in achieving better outcomes while also protecting privacy by using de-identified tokens to track patients.

“Our mission at Komodo Health is to reduce the global burden of disease,” Lauren Stahl, vice president and head of partnerships, healthcare solutions at data and analytics startup Komodo Health, said in this interview with Beet.TV. “We build software applications and solutions on top our healthcare map to support a number of different use cases.”

The clinical data have applications for healthcare marketers that seek to improve the effectiveness of their efforts to reach patients and medical professionals.

“You’re able to get the right message to the right healthcare provider — all of our data identified at the healthcare provider level — to the right patient at the right time,” Stahl said. “You can look at the market, you can assess the landscape based on actual disease burden.”

The company works with DeepIntent, a demand-side platform (DSP) for programmatic advertisers in the healthcare industry.

“DeepIntent is one of those visionary companies where what they are doing as an organization very much aligns with what we are doing,” Stahl said. “Really, it’s all about improving the patient’s quality of life, ensuring they’re getting access to the right treatment at the right time.”

DeepIntent provides tools for advertising attribution, a holistic view of healthcare providers and patients and timely reporting. The company supports multiple parts of the healthcare industry including life sciences businesses, agencies and marketing technology firms.

“Our partnership allows DeepIntent to deliver unprecedented ability to run, to manage, to measure these campaigns all within a single platform,” Stahl said. “Marketers, publishers can really now qualify campaign-specific audiences. They can serve relevant, informative ads with unprecedented speed and precision — and they can measure that real-world effectiveness as advertisers on patients and providers.”

You are watching “Embracing the Future of Healthcare Marketing,” a Beet.TV leadership series presented by DeepIntent. For more videos, please visit this page.